Why weren’t any of the genius that are trying to sell us a tip to get us to buy their newsletter pushing Tobira(TBRA) ? It was purchased by Allergan yesterday and went from 4$ to 38$ a share! Newsletter buyers beware.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.